The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine
... induced the highest rates
of subjects with a
titer (antibody concentration in the blood) more ... demonstrating a more than four-fold increase in
titer after
immunization, the highest responses were ... and 78.0 percent, respectively, with
neutralizing
titer more than 1:20). The responses against the clade ...
Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization
... non-toxic concentrations were shown to cause 100fold reductions in IBV
titer with no noticeable adverse effects on embryo developing chicks. -- ... has been determined that provides a significant log reduction in viral
titer in the trachea of 2 week old SPF chickens treated with QR448(a) 2 ...
Merz Pharmaceuticals Announce Three Studies of NT-201 - (Botulinum neurotoxin type A Free From Complexing Proteins)
... from 56.3% to 85.3%). During the 1-year trial period, adverse events were observed in 56.6% of patients. None of the patients had positive antibody
titer tested in the mouse diaphragm assay.
About Merz
Merz (KGAa) is known worldwide for its development of original compounds and formulations ...
Novavax Presents Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program at World Health Organization Conference
... against drifted (i.e., mutated) strains.
Addressing the Gaps in the System
"These data, coupled with the strong neutralizing antibody
titer data from this study disclosed last year, demonstrate that the Novavax recombinant VLP vaccine is a valid and potent approach against pandemic ...
Novavax Announces Top Line Results of Phase IIa Clinical Trial for Its Seasonal Influenza VLP (Trivalent) Vaccine Candidate
... H3N2, 83 to 94% for H1N1, and 73 to 79% for B. Seroconversion rates (i.e., percentage of subjects with greater than or equal to 4 fold rise in HAI
titer from baseline) ranged from 90 to 100% for H3N2, 69 to 78% for H1N1, and 42 to 56% for B among subjects who did not have antibodies to these strains ...
Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting
... changes were completely prevented
in the group on larazotide acetate.
-- There was a small, not statistically significant increase in the
anti-tTG
titer in the placebo (control) group, which was prevented in the
group on larazotide acetate.
-- Other trends in specific monocyte populations induced by ...
Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
... the VLPs were given in a
monovalent formulation. Three different dosages of the trivalent vaccine
were given; the anti-hemagglutinin (HI) antibody
titer increased with
dosage and protective levels of HI antibody titers were observed against
each subtype at a dose of 3 g of hemagglutinin.
This ...
New England Journal of Medicine Publishes New Data on Gardasil,
Merck's Cervical Cancer Vaccine
... Geometric Mean
titer Geometric Mean Titer
n*** ... 160 days Postdose 2.
Note: GMT = Geometric mean
titer in mMU/mL (mMU = milli-Merck ... GMT = Geometric mean
titer in mMU/mL (mMU = milli-Merck ...
Data Published in The Lancet Show Gardasil was 100 Percent
Effective in Preventing High-Grade Vulvar and Vaginal Lesions
Caused by HPV Types 16 and 18
... Geometric Mean
titer Geometric Mean Titer
n*** ... 160 days Postdose 2.
Note: GMT = Geometric mean
titer in mMU/mL (mMU = milli-Merck ... GMT = Geometric mean
titer in mMU/mL (mMU = milli-Merck ...
AVI BioPharma Reports Positive Pre-Clinical Influenza Data
... (weight loss) and increased survival compared to control
treated and untreated mice. In addition, PMO-treated mice showed
significantly reduced viral
titer (to below limit of detection) in
comparison to untreated mice. Histological examination of the lungs
showed that treated mice had reduced pathology ...
HepaLife Announces Scientific Presentation of PBS-1 Cell Line at
International Influenza Meeting
... vaccine production at the "Options for the
Control of Influenza VI Conference," to be held June 17-23, 2007,
in Toronto, Canada.
Entitled "High
titer growth of human and avian influenza viruses
in an immortalized chick embryo cell line without the need for
exogenous proteases," and presented by ....
HepaLife's PBS-1 Cells for Influenza Vaccine Production Prove
Superior at International Conference
... blind influenza virus received from human
respiratory samples were successfully identified as type-A
influenza using PBS-1 cells.
Entitled "High
titer growth of human and avian influenza viruses
in an immortalized chick embryo cell line without the need for
exogenous proteases," this new data was ...